{
  "id": 196,
  "text": "In IGABT, the planning aim should be to deliver a brachytherapy dose of 40 to 45 Gy (EQD2) to reach a total EBRT $^ +$ brachytherapy dose of equal to or greater than 85 to 90 Gy EQD2 (D90) (assuming 45 Gy through EBRT) to the CTV- $\\cdot \\mathrm { T } _ { \\mathrm { H R } } ,$ equal to or greater than 60 Gy (D98) to the CTV- $\\cdot \\mathrm { T } _ { \\mathrm { I R } } ,$ and equal to or greater than 90 Gy (D98) to the GTV- $\\cdot \\mathrm { T } _ { \\mathrm { r e s } }$ .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: In IGABT, the planning aim should be to deliver a brachytherapy dose of 40 to 45 Gy (EQD2) to reach a total EBRT $^ +$ brachytherapy dose of equal to or greater than 85 to 90 Gy EQD2 (D90) (assuming 45 Gy through EBRT) to the CTV- $\\cdot \\mathrm { T } _ { \\mathrm { H R } } ,$ equal to or greater than 60 Gy (D98) to the CTV- $\\cdot \\mathrm { T } _ { \\mathrm { I R } } ,$ and equal to or greater than\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "为了确保宫颈癌患者在后装治疗中达到CTV-THR的总剂量（包括外放疗和后装治疗）至少85-90 Gy EQD2，首先需要在外放疗中提供大约45 Gy的剂量。然后在后装治疗中计划提供额外40-45 Gy的剂量。这样总剂量可达或超过规定的目标剂量。此外，需要确保CTV-TIR的剂量要求，应该达到或超过60 Gy (D98)。在进行剂量计划时，需要准确计算和优化每个目标区域的剂量分布，确保靶区得到充分的覆盖，同时注意周围正常组织的保护。通过合理的放射治疗计划和技术措施，能够实现这些剂量要求，从而提高治疗效果和患者的预后。",
  "query": "**在宫颈癌的后装治疗中，如何规划以确保CTV-THR的总剂量（包括外放疗和后装治疗）达到或超过85-90 Gy EQD2，同时满足CTV-TIR的剂量要求？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **在宫颈癌的后装治疗中，如何规划以确保CTV-THR的总剂量（包括外放疗和后装治疗）达到或超过85-90 Gy EQD2，同时满足CTV-TIR的剂量要求？**\n\n<reference text>: In IGABT, the planning aim should be to deliver a brachytherapy dose of 40 to 45 Gy (EQD2) to reach a total EBRT $^ +$ brachytherapy dose of equal to or greater than 85 to 90 Gy EQD2 (D90) (assuming 45 Gy through EBRT) to the CTV- $\\cdot \\mathrm { T } _ { \\mathrm { H R } } ,$ equal to or greater than 60 Gy (D98) to the CTV- $\\cdot \\mathrm { T } _ { \\mathrm { I R } } ,$ and equal to or greater than 90 Gy (D98) to the GTV- $\\cdot \\mathrm { T } _ { \\mathrm { r e s } }$ .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "为了确保宫颈癌患者在后装治疗中达到CTV-THR的总剂量（包括外放疗和后装治疗）至少85-90 Gy EQD2，首先需要在外放疗中提供大约45 Gy的剂量。然后在后装治疗中计划提供额外40-45 Gy的剂量。这样总剂量可达或超过规定的目标剂量。此外，需要确保CTV-TIR的剂量要求，应该达到或超过60 Gy (D98)。在进行剂量计划时，需要准确计算和优化每个目标区域的剂量分布，确保靶区得到充分的覆盖，同时注意周围正常组织的保护。通过合理的放射治疗计划和技术措施，能够实现这些剂量要求，从而提高治疗效果和患者的预后。"
}